Home/Filings/4/0001209191-17-061614
4//SEC Filing

Templeman Blaine 4

Accession 0001209191-17-061614

CIK 0001435049other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 6:43 PM ET

Size

5.0 KB

Accession

0001209191-17-061614

Insider Transaction Report

Form 4
Period: 2017-11-17
Templeman Blaine
Executive VP, General Counsel
Transactions
  • Sale

    Common Stock

    2017-11-17$8.85/sh243$2,15158,834 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
  • [F2]Includes 243 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on November 15, 2017.

Issuer

ADURO BIOTECH, INC.

CIK 0001435049

Entity typeother

Related Parties

1
  • filerCIK 0001653641

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:43 PM ET
Size
5.0 KB